Back to top

Image: Bigstock

Why Sucampo Pharmaceuticals (SCMP)Could Be an Impressive Growth Stock

Read MoreHide Full Article

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.

One such company that might be well-positioned for future earnings growth is Sucampo Pharmaceuticals, Inc. . This firm, which is in the Medical - Drugs, saw significant EPS growth  last year, and is looking great for this year too.

In fact, the current growth estimate for this year calls for earnings-per-share growth of 42.2%. Furthermore, the long-term growth rate is currently an impressive 17%, suggesting pretty good prospects for the long haul.

SUCAMPO PHARMAC Price and Consensus

SUCAMPO PHARMAC Price and Consensus | SUCAMPO PHARMAC Quote

And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 10%. Thanks to this rise in earnings estimates, SCMP has a Zacks Rank #1 (Strong Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today’s Zacks #1 Rank  stocks here.

So if you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider SCMP. Not only does it have double digit earnings growth prospect, but its impressive Zacks Rank suggests that analysts believe better days are ahead for SCMP as well.

Zacks' Top 10 Stocks for 2017

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?

Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>

Published in